相关实验视频

Updated: Apr 28, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

11.0K

为编程细胞死亡受体-1解封基因组生物标志物 免疫疗法在使用深度神经网络的非小细胞肺癌中取得成功:定量研究

Rayan Mubarak1, Fahim Islam Anik2, Jean T Rodriguez3

  • 1Cypress Bay High School, Weston, FL, United States.

JMIR bioinformatics and biotechnology
|January 13, 2026
PubMed
概括

这项研究使用深度学习来识别PD-1免疫疗法的非小细胞肺癌 (NSCLC) 患者的基因组生物标志物. 深度免疫基因模型确定了36个关键基因,提高了个性化治疗策略的预测准确度.

关键词:
深度免疫基因 (DeepImmunoGene) 是一种深度免疫基因.通过RNA-seq分析进行分析.生物标志物 生物标志物深度神经网络是一个神经网络.不同的基因表达方式免疫疗法 免疫疗法肺癌是一种肺癌.机器学习是机器学习.编程细胞死亡受体-1

更多相关视频

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

11.0K
Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

5.6K

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K